Chimerix Inc (NASDAQ:CMRX)

34.77
Data as of Nov 21
 +0.95 / +2.81%
Today’s Change
13.29
Today|||52-Week Range
36.75
+130.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.4B

Company Description

Chimerix, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel, oral antiviral therapeutics designed to transform patient care in areas of unmet medical need. Its proprietary lipid technology has given rise to two clinical-stage lipid acyclic nucleoside phosphonates, CMX001 and CMX157, which have demonstrated the potential for enhanced activity and safety in convenient, orally administered dosing regimens. Chimerix's lead product candidate, CMX001, is a broad spectrum antiviral against double-stranded DNA viruses. CMX157, is an oral nucleotide compound in Phase 1 development for the treatment of HIV infection. The company was founded in April 2000 and is headquartered in Durham, NC.

Contact Information

Chimerix, Inc.
2505 Meridian Parkway
Durham North Carolina 27713
P:(919) 806-1074
Investor Relations:
(919) 972-7124

Employees

Shareholders

Mutual fund holders44.10%
Other institutional31.84%
Individual stakeholders22.56%

Top Executives

M. Michelle BerreyPresident, CEO, Director & Chief Medical Officer
Timothy W. TrostChief Financial Officer, Secretary & Senior VP
Hervé Momméja-MarinVice President-Clinical Research
William Garrett NicholsChief Medical Officer
Linda M. RichardsonChief Commercial Officer

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.